Johnson & Johnson ( JNJ) - Stock Earnings
JNJ Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 15, 2025 BeforeMarket | - / 2.5900000000 | 21.4 billion | - / 21.6 billion | 22.1 billion |
JNJ Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q3 | 2.7 billion USD | 22.5 billion USD |
| 2024Q2 | 4.7 billion USD | 22.4 billion USD |
| 2024Q1 | 3.3 billion USD | 21.4 billion USD |
| 2023Q4 | 4.0 billion USD | 21.4 billion USD |
| 2023Q3 | 26.0 billion USD | 21.4 billion USD |
JNJ Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 35.2 billion USD | 85.2 billion USD |
| 2022 | 17.9 billion USD | 80.0 billion USD |
| 2021 | 20.9 billion USD | 78.7 billion USD |
| 2020 | 14.7 billion USD | 82.6 billion USD |
| 2019 | 15.1 billion USD | 82.1 billion USD |
JNJ
List: Champions
Price: $163.14
Dividend Yield: 3.12%
Forward Dividend Yield: 3.04%
Payout Ratio: 75.04%
Dividend Per Share: 4.96 USD
Earnings Per Share: 5.79 USD
P/E Ratio: 28.57
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 6.9 million
Ebitda: 2.9 billionMarket Capitalization: 398.3 billion
Average Dividend Frequency: 4
Years Paying Dividends: 25
DGR3: 5.62%
DGR5: 5.75%
DGR10: 6.07%
DGR20: 8.40%